MetaVia Inc. — Director's Dealing 2024

Jul 10, 2024

SEC Form 4/A — Form 4/A

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2024-06-23

Reporting Person: DONG-A ST CO., LTD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-23	Common Stock	P	2544530	$3.93	Acquired	5348229	Direct

Footnotes

F1: This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.